, Tracking Stock Market Picks
Enter Symbol:

up 33.26 %

MEDIVATION INC (MDVN) rated Buy with price target $128 by Stifel

Posted on: Thursday,  Jan 29, 2015  8:25 AM ET by Stifel

Stifel rated Buy MEDIVATION INC (NASDAQ: MDVN) on 01/29/2015. Previously Stifel rated Buy MEDIVATION INC (NASDAQ: MDVN) on 05/22/2014., when
the stock price was $69.09. Since then, MEDIVATION INC has gained 33.26% as of 01/27/2016's recent price of $92.07.
If you would have followed the previous Stifel's recommendation on MDVN, you would have gained 33.26% of your investment in 615 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2015 8:25 AM Buy
105.28 128.00
as of 8/27/2015
1 Week down  -10.35 %
1 Month down  -20.67 %
3 Months down  -25.37 %
1 YTD down  -12.54 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2014 8:25 AM Buy
96.17 112.00
5/22/2014 12:00 AM Buy
69.09 81.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy